Hospira Woes Continue As Glass Contamination Spurs Recall

Law360, New York (October 3, 2013, 4:58 PM EDT) -- Beleaguered drugmaker Hospira Inc. on Tuesday said it’s recalling three lots of injectable drugs because the vials contain glass strands that could dislodge and harm patients, the latest addition to a laundry list of recent manufacturing problems for the pharmaceutical giant.

In a statement, Hospira blamed a supplier for defects that it said might cause minor injuries, such as vein inflammation, if glass particulates were to detach from the inner walls of vials and be injected into a patient. It’s also possible that the fragments could...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.